Do You Believe in Magic? –
February 7, 2019 – researchers from Johns Hopkins said the active ingredient in hallucinogenic mushrooms – psilocybin – has low abuse potential, and could reduce psychological distress and opioid abuse potential they would recommend reclassifying psilocybin from a schedule I drug – one that has no known medical potential – to a schedule IV drug – one that has low potential for abuse and dependence.
